SWOG clinical trial number
S9802
A Phase II Trial of Gemcitabine in Advanced Soft Tissue Sarcomas
Closed
Phase
Accrual
100%
Published
Abbreviated Title
Gemcitabine in Advanced Sarcoma
Activated
05/01/1998
Closed
03/15/1999
Publication Information Expand/Collapse
2006
Phase II trial of gemcitabine as first line chemotherapy in patients with metastatic or unresectable soft tissue sarcoma
2003
Phase II trial of gemcitabine as first line chemotherapy in patients with metastatic or unresectable soft tissue sarcomas (STS).